UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

British journal of dermatology (1951), 2004-11, Vol.151 (5), p.1004-1010

2004

Volltextzugriff (PDF)

Development of a novel ELISA system for detection of anti‐BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

British journal of dermatology (1951), 2004-11, Vol.151 (5), p.1004-1010

2004

Volltextzugriff (PDF)

Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis

Rheumatology (Oxford, England), 2006-01, Vol.45 (1), p.116-117

2006

Volltextzugriff (PDF)

Interleukin‐16 expression and release in bullous pemphigoid

Clinical and experimental immunology, 2004-09, Vol.137 (3), p.595-600

2004

Volltextzugriff (PDF)

Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Clinical and experimental rheumatology, 2007-03, Vol.25 (2), p.268

2007

Volltextzugriff (PDF)

Circulating Interleukin 16 (IL‐16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity

Allergy (Copenhagen), 2002-09, Vol.57 (9), p.815-820

2002

Volltextzugriff (PDF)

Oral Allergic Syndrome and Recombinant Allergens rBet v 1 and rBet v 2

European journal of inflammation, 2007-01, Vol.5 (1), p.21-25

2007

Volltextzugriff (PDF)

Soluble CD30 in pediatric patients with atopic dermatitis

Allergy (Copenhagen), 1997-01, Vol.52 (1), p.106-109

1997

Volltextzugriff (PDF)

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

Allergy (Copenhagen), 1999-05, Vol.54 (5), p.507-510

1999

Volltextzugriff (PDF)

Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus

Lupus, 1997-01, Vol.6 (4), p.415-417

1997

Volltextzugriff (PDF)

Dyshidrosiform Palmoplantar Pemphigoid in a Young Man: Response to Dapsone

Acta dermato-venereologica, 2010, Vol.90 (1), p.80-81

2010

Volltextzugriff (PDF)

T-helper 2 involvement in the pathogenesis of bullous pemphigoid : role of soluble CD30 (sCD30)

Archives of Dermatological Research, 1997-11, Vol.289 (12), p.667-670

1997

Volltextzugriff (PDF)

Psoriasis: comparison of immunological markers in patients with acute and remission phase

Journal of dermatological science, 1996-11, Vol.13 (2), p.118-124

1996

Volltextzugriff (PDF)

An Open Randomized Controlled Study on the Efficacy of Low-Sodium Water Intake Evaluated by Non-Invasive Methods in Patients with Cellulite

European journal of inflammation, 2003-01, Vol.1 (1), p.43-48

2003

Volltextzugriff (PDF)

FC002 Th2 involvement in the pathogenesis of bullous pemphigoid

Journal of the European Academy of Dermatology and Venereology, 1997-09, Vol.9, p.S115-S115

1997

Volltextzugriff (PDF)

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid

EJD. European journal of dermatology, 2002, Vol.12 (1), p.27-31

2002

Volltextzugriff (PDF)

Clinical and Laboratory Investigations: Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

British journal of dermatology (1951), 2004-11, Vol.151 (5), p.1004-1010

2004

Volltextzugriff (PDF)

Soluble CD30 (sCD30) in patients with Cutaneous T Cell Lymphoma (CTCL)

Journal of dermatological science, 1998-03, Vol.16, p.S189-S189

1998

Volltextzugriff (PDF)

Chromosome damage in a young woman with generalized morphea: cause or effect?

International journal of dermatology, 1999-06, Vol.38 (6), p.478

1999

Volltextzugriff (PDF)

In situ detection of eotaxin and CCR3 in bullous pemphigoid

Journal of the European Academy of Dermatology and Venereology, 1998-09, Vol.11, p.S137-S137

1998

Volltextzugriff (PDF)

Cyclosporine is able to reduce sCD30 serum levels in atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, 1998-09, Vol.11, p.S199-S199

1998

Volltextzugriff (PDF)

Intravenous immunoglobulin therapy: Modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus

Arthritis and rheumatism, 1996-04, Vol.39 (4), p.704-705

1996

Volltextzugriff (PDF)

Repeat skin biopsies of nonlesional skin in patients with systemic lupus erythematosus

Arthritis and rheumatism, 1983-10, Vol.26 (10), p.1294-1295

1983

Volltextzugriff (PDF)

Chromosome damage in a young woman with generalized morphea: cause or effect?

International journal of dermatology, 1999, Vol.38 (6), p.478-479

1999

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)
Berichte
(1)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

Development of a novel ELISA system for detection of anti‐BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis

Interleukin‐16 expression and release in bullous pemphigoid

Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Circulating Interleukin 16 (IL‐16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity

Oral Allergic Syndrome and Recombinant Allergens rBet v 1 and rBet v 2

Soluble CD30 in pediatric patients with atopic dermatitis

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus

Dyshidrosiform Palmoplantar Pemphigoid in a Young Man: Response to Dapsone

T-helper 2 involvement in the pathogenesis of bullous pemphigoid : role of soluble CD30 (sCD30)

Psoriasis: comparison of immunological markers in patients with acute and remission phase

An Open Randomized Controlled Study on the Efficacy of Low-Sodium Water Intake Evaluated by Non-Invasive Methods in Patients with Cellulite

FC002 Th2 involvement in the pathogenesis of bullous pemphigoid

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid

Clinical and Laboratory Investigations: Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

Soluble CD30 (sCD30) in patients with Cutaneous T Cell Lymphoma (CTCL)

Chromosome damage in a young woman with generalized morphea: cause or effect?

In situ detection of eotaxin and CCR3 in bullous pemphigoid

Cyclosporine is able to reduce sCD30 serum levels in atopic dermatitis

Intravenous immunoglobulin therapy: Modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus

Repeat skin biopsies of nonlesional skin in patients with systemic lupus erythematosus

Chromosome damage in a young woman with generalized morphea: cause or effect?

Suchergebnisse filtern